About
Therapeutic cancer vaccines and proteostasis modulators
Areas of Focus
Categories
VaccineGene Therapy, RNA & Peptide Therapy
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
151
By Phase
PHASE2: 3PHASE1: 1
By Status
NOT_YET_RECRUITING: 1RECRUITING: 1TERMINATED: 1UNKNOWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05794659Lead Sponsor
Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer
PHASE2Not yet recruiting
98 participants
Started: Nov 15, 2023 · Completed: Nov 15, 2027
NCT05771584Lead Sponsor
Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Gastric Cancer
PHASE2Recruiting
24 participants
Started: Jul 4, 2023 · Completed: Jun 15, 2026
NCT05163223Lead Sponsor
Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer
PHASE2Terminated
10 participants
Started: Feb 28, 2022 · Completed: May 31, 2024
NCT04864418Lead Sponsor
AST-021p Study in Advanced Solid Tumors
PHASE1Unknown
19 participants
Started: Jun 9, 2021 · Completed: Nov 30, 2023
Locations (1)
Headquarters
Seoul, Korea
Map
Loading map...